Growing community of inventors

Buc, France

Pascal Collin

Average Co-Inventor Count = 8.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Pascal CollinJoanna Bakala (2 patents)Pascal CollinJérôme Bignon (7 patents)Pascal CollinMaria Conception Achab (2 patents)Pascal CollinBernard Delpech (2 patents)Pascal CollinMaxim Egorov (1 patent)Pascal CollinBogdan Iorga (1 patent)Pascal CollinFranck Pelissier (1 patent)Pascal CollinJérome Bignon (1 patent)Pascal CollinOdile Thoison (1 patent)Pascal CollinMichel Benechie (1 patent)Pascal CollinYves-Michel Frapart-Jannuad (1 patent)Pascal CollinFabienne Peyrot (1 patent)Pascal CollinYves-Michel Frapart-Jannaud (1 patent)Pascal CollinYves-Michel Frapart-Jannaud (0 patent)Pascal CollinMaria Achab (0 patent)Pascal CollinPascal Collin (2 patents)Joanna BakalaJoanna Bakala (10 patents)Jérôme BignonJérôme Bignon (7 patents)Maria Conception AchabMaria Conception Achab (3 patents)Bernard DelpechBernard Delpech (2 patents)Maxim EgorovMaxim Egorov (4 patents)Bogdan IorgaBogdan Iorga (2 patents)Franck PelissierFranck Pelissier (1 patent)Jérome BignonJérome Bignon (1 patent)Odile ThoisonOdile Thoison (1 patent)Michel BenechieMichel Benechie (1 patent)Yves-Michel Frapart-JannuadYves-Michel Frapart-Jannuad (1 patent)Fabienne PeyrotFabienne Peyrot (1 patent)Yves-Michel Frapart-JannaudYves-Michel Frapart-Jannaud (1 patent)Yves-Michel Frapart-JannaudYves-Michel Frapart-Jannaud (0 patent)Maria AchabMaria Achab (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Centre National De La Recherche Scientifique (2 from 5,089 patents)


2 patents:

1. 10233151 - Use of a novel 3-aryl-4-catechol-pyrrole-N-propanol compound and the derivatives thereof to treat cancer and diseases related to excessive angiogenesis

2. 9546159 - N-substituted 3,4-bis (catechol) pyrrole compounds, and the preparation and use thereof in the treatment of cancer

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/3/2026
Loading…